Abstract: Involved is an isolated antigen binding protein, being capable of binding CCR8 derived from a primate animal. Further involved are a pharmaceutical composition comprising the antigen binding protein, and an application of the antigen binding protein and/or the pharmaceutical composition in the prevention and/or treatment of a tumor or a cancer.

Abstract: A reusable protective clothing includes a one-piece protective suit which includes integrated top and trousers attached with gloves and shoe covers, and a protective headpiece having a face shield. A front side of the protective headpiece is provided with a full-vision goggle with 180-degree field of view, the full-vision goggle is integrated with the face shield, a back side of the protective headpiece is provided with a protective hood made of a material of the one-piece protective suit, the protective hood is integrated with the top, the front side of the protective headpiece is provided with an air vent for a mouth and a nose configured according to facial features of a wearer, and an outer side of the protective headpiece is provided with ear-shaped hooks. The protective clothing is designed according to application environment and medical requirements to prevent exposure to pathogenic microorganisms.

Abstract: The present disclosure relates to a method and system for evaluating the macro resilience of offshore oil well control equipment. The method for evaluating the macro resilience of offshore oil well control equipment comprises six steps: determining the type and strength of external disaster; calculating the failure rate of components; calculating the recovery rate of the components; modeling the BN for a degradation process; modeling the BN for a maintenance process; and calculating the resilience of the offshore oil well control equipment. A system for evaluating the macro resilience of offshore oil well control equipment comprises an external disaster evaluation module, a component failure rate calculation subsystem, a reliability degradation process simulation module, a fault identification module, a component recovery rate calculation module, a reliability recovery process simulation module, a reliability change curve derivation unit and an resilience calculation unit.

Abstract: An Electric and Magnetic Fields (EMF) protection device, includes: a metallic bottom; a metallic side extending from the metallic bottom; and a top opening, wherein the metallic bottom and the metallic side form a cylinder enclosure configured to substantially block a signal passing through the metallic side and the metallic bottom and allow the signal to pass only through the top opening.

Abstract: A strict reverse navigation method for optimal estimation of fine alignment is provided. The strict reverse navigation method including: establishing an adaptive control function; performing a forward navigation calculation process; performing a reverse navigation calculation process; and performing the adaptive control for a number of forward and reverse calculations. The strict reverse navigation method shortens an alignment time for the optimal estimation of fine alignment while ensuring an alignment accuracy. The strict reverse navigation method provided effectively solves a problem that an error of an initial value of filtering in an initial stage of the optimal estimation of fine alignment affects convergence speeds of subsequent stages. In the initial stage, a larger number of the forward and reverse navigation calculations are adopted to reduce an error of the initial value as much as possible and increase a convergence speed of the filtering.

Abstract: A 99mTc-labeled isonitrile-containing glucose derivative having the general formula [99mTc-(CNDG)6]+, preparation method and use thereof is disclosed herein. The derivative is centered on 99mTc+, and the carbon atom of the isonitrile in CNDG coordinates with 99mTc(I) to form a hexacoordinated complex [99mTc-(CNDG)6]+. The [99mTc-(CNDG)6]+ derivative was obtained by the synthesis of the ligand CNDG and the preparation of the lyophilized CNDG kit. The derivative of this disclosure has good stability, simple preparation, high uptake and good retention at a tumor site, and high tumor/non-target ratio, and it is a novel 99mTc-labeled isonitrile-containing glucose derivative with excellent performance for tumor imaging. The derivative of this disclosure is advantageous for popularization and application.

Abstract: An Electric and Magnetic Fields (EMF) protection device, includes: a metallic bottom; a metallic side extending from the metallic bottom; and a top opening, wherein the metallic bottom and the metallic side form a cylinder enclosure configured to substantially block a signal passing through the metallic side and the metallic bottom and allow the signal to pass only through the top opening.

Abstract: A strict reverse navigation method for optimal estimation of fine alignment is provided. The strict reverse navigation method including: establishing an adaptive control function; performing a forward navigation calculation process; performing a reverse navigation calculation process; and performing the adaptive control for a number of forward and reverse calculations. The strict reverse navigation method shortens an alignment time for the optimal estimation of fine alignment while ensuring an alignment accuracy. The strict reverse navigation method provided effectively solves a problem that an error of an initial value of filtering in an initial stage of the optimal estimation of fine alignment affects convergence speeds of subsequent stages. In the initial stage, a larger number of the forward and reverse navigation calculations are adopted to reduce an error of the initial value as much as possible and increase a convergence speed of the filtering.

Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.

Abstract: A 99mTc-labeled isonitrile-containing glucose derivative having the general formula [99mTc-(CNDG)6]+, preparation method and use thereof is disclosed herein. The derivative is centered on 99mTc+, and the carbon atom of the isonitrile in CNDG coordinates with 99mTc(I) to form a hexacoordinated complex [99mTc-(CNDG)6]+. The [99mTc-(CNDG)6]+ derivative was obtained by the synthesis of the ligand CNDG and the preparation of the lyophilized CNDG kit. The derivative of the present invention this disclosure has good stability, simple preparation, high uptake and good retention at a tumor site, and high tumor/non-target ratio, and it is a novel 99mTc-labeled isonitrile-containing glucose derivative with excellent performance for tumor imaging. The derivative of the present invention this disclosure is advantageous for popularization and application.

Abstract: A control circuit, a testing apparatus and a method for testing a liquid crystal display panel are provided. The control circuit includes a current sensor and a discharge signal generation circuit. The current sensor is configured to detect a change in an input current of the liquid crystal display panel to generate an indication signal, the indication signal being indicative of switching of image frames displayed by the liquid crystal display panel. The discharge signal generation circuit is configured to receive the indication signal from the current sensor, and the discharge signal generation circuit generates a discharge signal in response to receiving the indication signal, so that a liquid crystal capacitor including the common electrode and the pixel electrode in the liquid crystal display panel is discharged. Hence, the quality of images displayed by the liquid crystal display panel can be improved and the product yield can be increased.

Abstract: A control circuit, a testing apparatus and a method for testing a liquid crystal display panel are provided. The control circuit includes a current sensor and a discharge signal generation circuit. The current sensor is configured to detect a change in an input current of the liquid crystal display panel to generate an indication signal, the indication signal being indicative of switching of image frames displayed by the liquid crystal display panel. The discharge signal generation circuit is configured to receive the indication signal from the current sensor, and the discharge signal generation circuit generates a discharge signal in response to receiving the indication signal, so that a liquid crystal capacitor including the common electrode and the pixel electrode in the liquid crystal display panel is discharged. Hence, the quality of images displayed by the liquid crystal display panel can be improved and the product yield can be increased.

Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.

Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.

Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.

Abstract: A controlling method includes obtaining a triggering event and controlling, based on the triggering event, a camera of an electronic apparatus to be in an operation mode corresponding to the triggering event. The triggering event is one of a plurality of types of events. The plurality of types of events include a first-type event and a second-type event that are different from each other.

Abstract: An article with a body having spaced channels created at a surface of the body and extending into the body, wherein the channels are located at controlled spaced locations. The channeled or microchanneled articles may be in the form of channeled or microchanneled membranes or otherwise. Methods of manufacturing channeled articles and uses of the channeled articles are described.

Abstract: A controlling method includes obtaining a triggering event and controlling, based on the triggering event, a camera of an electronic apparatus to be in an operation mode corresponding to the triggering event. The triggering event is one of a plurality of types of events. The plurality of types of events include a first-type event and a second-type event that are different from each other.

Abstract: An article with a body having spaced channels created at a surface of the body and extending into the body, wherein the channels are located at controlled spaced locations. The channeled or microchanneled articles may be in the form of channeled or microchanneled membranes or otherwise. Methods of manufacturing channeled articles and uses of the channeled articles are described.